ArticleMMWR. Morbidity and mortality weekly report2024

Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19-Related Thromboembolic Events Among Medicare Enrollees Aged ≥65 Years and Those with End Stage Renal Disease - United States, September 2022-March 2023.

Amanda B Payne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.